March 2009
Advertisement
Advertisement
Trending on HCPLive
1
Omalizumab-Facilitated OIT Enables Maintenance Dosing in Food Allergy
2
VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes
3
New Liver Cancer BEACON-HCC Framework Shows 96.6% Concordance in Pilot
4
After Sickle Cell Gene Therapy, What Comes Next?
5